Abbott's Baby Formula Brouhaha: Judge Says No Harm, No Foul in Contamination Controversy

Comments
Loading...

U.S. District Judge Matthew Kennelly in Chicago dismissed claims by parents pursuing only "economic loss" claims related to Abbott Laboratories ABT Similac and other formulas that they said had a "substantial risk" of bacteria contamination.

The parents said they would not have bought or paid less for formula but for the company's claims that it was safe.

Related: Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage.

Last February, Abbott recalled powdered baby formulas, including Similac, made at a Michigan facility after four consumers complained about bacterial infections in infants who consumed the products.

The judge said the parents lacked standing to sue, Reuters reported, as they did not show which Abbott products/lots were contaminated or their children experienced symptoms.

"In short, the plaintiffs received exactly what they say they bargained for safe infant formula," Kennelly wrote.

The judge also issued decisions that narrowed but did not dismiss two related lawsuits against Abbott.

Amid backlash for slow response to the formula shortage, the FDA proposed consolidating and streamlining its food division.

Last week, a New York City woman sued Abbott, accusing them of misleading consumers into believing its PediaSure nutrition drinks were "clinically proven" to increase children's height.

Price Action: ABT shares are down 1.89% at $106.19 on the last check Tuesday.

Photo by Pexels from Pixabay

ABT Logo
ABTAbbott Laboratories
$131.970.47%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum80.16
Growth64.73
Quality68.40
Value43.49
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In: